The results obtained will thus simplify the translation towards the clinical use of NfL in dementia by providing helpful information on NfL levels in a biofluid widely available, such as plasma; and by reporting the first publicly available data on the relationship between plasma NfL levels measured in parallel by SiMoA and Ella. The gene discussed is NEFL; the disease is dementia.